Impax Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Impax Asset Management's JNJ Position: Q2 2018 in Review
Impax Asset Management reduced its Johnson & Johnson (JNJ) stake by 81% in Q2 2018, selling an estimated $16.8M and leaving 31,751 shares worth $3.85M. The position accounts for 0.23% of the portfolio, ranked #113.
Impax Asset Management first reported a position in JNJ in Q4 2015 and has held it in 11 quarters since. The position peaked at $37.2M in Q2 2016. 2,593 funds tracked by Wall St. Rank hold JNJ as of Q2 2018.
- Impax Asset Management held 31,751 shares of Johnson & Johnson worth $3.85M as of Q2 2018.
- Impax Asset Management sold 134,757 Johnson & Johnson shares in Q2 2018, an estimated $16.8M.
- Johnson & Johnson made up 0.23% of Impax Asset Management's portfolio in Q2 2018, its #113 holding.
- Impax Asset Management first reported a position in Johnson & Johnson in Q4 2015 and has held it in 11 quarters since.
- Impax Asset Management's Johnson & Johnson position peaked at $37.2M in Q2 2016.
- 2,593 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2018.
Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.